Outliers? [BE/BA News]

posted by mittyri  – Russia, 2022-12-02 23:52 (1279 d 01:33 ago) – Posting: # 23382
Views: 19,130

Hi Helmut,

❝ Three options.

❝

  1. Hire a consultant with a SAS license.

    ❝

  2. AFAIK, the FDA recalculates all studies. Cross fingers.

    ❝

  3. Wait till someone publishes a paper about cross-validation. ;-)

I'll cross fingers to have that omitted from the final guidance (even if I do not plan to submit to FDA anything:-D; FDA guidelines are getting used to penetrate across the world).

❝ As an aside:

❝ How to assess ‘outliers’ in RSABE?

the only one method I can recall is described by Mr.Schall with coauthors
But I know that your question is not trivial and deeper than that.

PS: what is wrong with the format of cited list?
—
Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
443 visitors (0 registered, 443 guests [including 41 identified bots]).
Forum time: 02:26 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5